TFF Pharmaceuticals, Inc. (TFFP)
Dec 13, 2024 - TFFP was delisted (reason: winding down operations)
0.0650
-0.0977 (-60.05%)
Inactive · Last trade price
on Dec 12, 2024
TFF Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 2.61 | 5.48 | 16.61 | 33.79 | 35.3 | 28.09 | Upgrade
|
| Cash & Short-Term Investments | 2.61 | 5.48 | 16.61 | 33.79 | 35.3 | 28.09 | Upgrade
|
| Cash Growth | -73.20% | -67.02% | -50.84% | -4.27% | 25.65% | 173.79% | Upgrade
|
| Accounts Receivable | - | - | - | 0.01 | - | - | Upgrade
|
| Other Receivables | 0.31 | 0.43 | 0.19 | 2.6 | - | - | Upgrade
|
| Receivables | 0.31 | 0.43 | 0.19 | 2.61 | - | - | Upgrade
|
| Prepaid Expenses | 0.59 | 1.68 | 2.23 | 2.44 | 2.26 | 1.09 | Upgrade
|
| Total Current Assets | 3.51 | 7.59 | 19.03 | 38.84 | 37.56 | 29.19 | Upgrade
|
| Property, Plant & Equipment | 1.7 | 2.12 | 3.27 | 1.86 | 1.1 | - | Upgrade
|
| Other Long-Term Assets | 0.1 | 0.01 | 0.01 | - | - | - | Upgrade
|
| Total Assets | 7.08 | 12.03 | 24.12 | 40.7 | 38.66 | 29.19 | Upgrade
|
| Accounts Payable | 1.64 | 0.96 | 0.92 | 1.49 | 1.3 | 0.41 | Upgrade
|
| Accrued Expenses | 1.99 | 1.29 | 0 | 0.42 | - | - | Upgrade
|
| Current Portion of Leases | 0.05 | 0.08 | 0.08 | - | - | - | Upgrade
|
| Current Unearned Revenue | 0.25 | 0.1 | 0.13 | 0.05 | 0.02 | - | Upgrade
|
| Total Current Liabilities | 3.94 | 2.43 | 1.13 | 1.96 | 1.32 | 0.41 | Upgrade
|
| Long-Term Leases | - | 0.03 | 0.11 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 1.13 | Upgrade
|
| Total Liabilities | 3.94 | 2.46 | 1.24 | 1.96 | 1.32 | 1.54 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 135.39 | 128.04 | 120.11 | 104.08 | 71.65 | 43.34 | Upgrade
|
| Retained Earnings | -132.09 | -118.33 | -97.09 | -65.32 | -34.28 | -15.71 | Upgrade
|
| Comprehensive Income & Other | -0.17 | -0.15 | -0.14 | -0.05 | -0.05 | - | Upgrade
|
| Total Common Equity | 3.14 | 9.57 | 22.88 | 38.74 | 37.34 | 27.64 | Upgrade
|
| Shareholders' Equity | 3.14 | 9.57 | 22.88 | 38.74 | 37.34 | 27.64 | Upgrade
|
| Total Liabilities & Equity | 7.08 | 12.03 | 24.12 | 40.7 | 38.66 | 29.19 | Upgrade
|
| Total Debt | 0.05 | 0.12 | 0.19 | - | - | - | Upgrade
|
| Net Cash (Debt) | 2.55 | 5.36 | 16.42 | 33.79 | 35.3 | 28.09 | Upgrade
|
| Net Cash Growth | -73.37% | -67.34% | -51.41% | -4.27% | 25.65% | 173.79% | Upgrade
|
| Net Cash Per Share | 0.80 | 2.99 | 13.69 | 34.04 | 43.21 | 101.72 | Upgrade
|
| Filing Date Shares Outstanding | 4.44 | 2.52 | 1.45 | 1.01 | 0.93 | 0.75 | Upgrade
|
| Total Common Shares Outstanding | 3.54 | 2.37 | 1.45 | 1.01 | 0.9 | 0.74 | Upgrade
|
| Working Capital | -0.43 | 5.16 | 17.89 | 36.88 | 36.24 | 28.78 | Upgrade
|
| Book Value Per Share | 0.89 | 4.04 | 15.80 | 38.17 | 41.42 | 37.46 | Upgrade
|
| Tangible Book Value | 3.14 | 9.57 | 22.88 | 38.74 | 37.34 | 27.64 | Upgrade
|
| Tangible Book Value Per Share | 0.89 | 4.04 | 15.80 | 38.17 | 41.42 | 37.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.